Alphatec Holdings (ATEC) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Alphatec Holdings | 1.15 Bn | 1.01 Bn | 136.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.53% |
| Dec 31, 2025 | 31.29% |
| Sep 30, 2025 | 29.23% |
| Jun 30, 2025 | 27.84% |
| Mar 31, 2025 | 44.29% |
| Dec 31, 2024 | 44.74% |
| Sep 30, 2024 | 37.12% |
| Jun 30, 2024 | 48.47% |
| Mar 31, 2024 | 60.79% |
| Dec 31, 2023 | 61.59% |
| Sep 30, 2023 | 188.75% |
| Jun 30, 2023 | 199.74% |
| Mar 31, 2023 | 92.73% |
| Dec 31, 2022 | 108.62% |
| Sep 30, 2022 | 89.78% |
| Jun 30, 2022 | 86.22% |
| Mar 31, 2022 | 66.00% |
| Dec 31, 2021 | 142.49% |
| Sep 30, 2021 | 56.46% |
| Jun 30, 2021 | 106.66% |
| Mar 31, 2021 | 138.48% |
| Dec 31, 2020 | 89.59% |
| Sep 30, 2020 | 126.99% |
| Jun 30, 2020 | 29.32% |
| Mar 31, 2020 | 23.28% |
| Dec 31, 2019 | 30.00% |
| Sep 30, 2019 | 19.12% |
| Jun 30, 2019 | 14.49% |
| Mar 31, 2019 | 11.30% |
| Dec 31, 2018 | 8.37% |
| Sep 30, 2018 | -34.87% |
| Jun 30, 2018 | -33.94% |
| Mar 31, 2018 | -12.16% |
| Dec 31, 2017 | -16.89% |
| Sep 30, 2017 | -14.76% |
| Jun 30, 2017 | -9.12% |
| Mar 31, 2017 | 8.11% |
| Dec 31, 2016 | -25.25% |
| Sep 30, 2016 | 19.03% |
| Jun 30, 2016 | -16.11% |
| Mar 31, 2016 | -39.47% |
| Dec 31, 2015 | -24.92% |
| Sep 30, 2015 | -16.39% |